STIM1 / GOK (23-213, Calmodulin Tag) Human Protein
Specifications
| Product Data | |
| Species | Human |
|---|---|
| Expression Host | E. coli |
| Expression cDNA Clone or AA Sequence | |
| Tag | Calmodulin Tag |
| Predicted MW | 38 kDa (343aa) confirmed by MALDI-TOF |
| Concentration | 1mg/ml (determined by Bradford assay) |
| Purity | > 90% by SDS-PAGE |
| Presentation State | Purified |
| Buffer | Liquid in. 20mM Tris-HCl buffer (pH 7.5) |
| Preparation | Liquid purified protein |
| Recommended Dilution | SDS-PAGE |
| Protein Description | Recombinant Calmodulin tagged STIM1 was expressed in E.coli and purified by using conventional chromatography techniques. |
| Storage | Can be stored at +2°C to +8°C for 1 week. For long term storage, aliquot and store at -20°C to -80C. Avoid repeated freezing and thawing cycles. |
| Stability | Shelf life: one year from despatch. |
| Shipping | Blue Ice |
| Reference Data | |
| RefSeq | NP_003147 |
| Locus ID | 6786 |
| UniProt ID | Q13586 |
| Cytogenetics | 11p15.4 |
| Synonyms | Stromal interaction molecule 1, GOK, D11S4896E, Stromal interaction molecule 1, STIM1, Stromal interaction molecule 1 D11S4896E, SIM, STIM 1, Stim1 stromal interaction molecule 1. |
| Summary | This gene encodes a type 1 transmembrane protein that mediates Ca2+ influx after depletion of intracellular Ca2+ stores by gating of store-operated Ca2+ influx channels (SOCs). It is one of several genes located in the imprinted gene domain of 11p15.5, an important tumor-suppressor gene region. Alterations in this region have been associated with the Beckwith-Wiedemann syndrome, Wilms tumor, rhabdomyosarcoma, adrenocrotical carcinoma, and lung, ovarian, and breast cancer. This gene may play a role in malignancies and disease that involve this region, as well as early hematopoiesis, by mediating attachment to stromal cells. Mutations in this gene are associated with fatal classic Kaposi sarcoma, immunodeficiency due to defects in store-operated calcium entry (SOCE) in fibroblasts, ectodermal dysplasia and tubular aggregate myopathy. This gene is oriented in a head-to-tail configuration with the ribonucleotide reductase 1 gene (RRM1), with the 3' end of this gene situated 1.6 kb from the 5' end of the RRM1 gene. Alternative splicing of this gene results in multiple transcript variants. provided by RefSeq, May 2013 |
| Protein Categories | Cardiovascular diseases, Immune system diseases, Intracellular Proteins, Membrane Proteins |
| Protein Families | Transmembrane |
Reviews
Documents
| FAQs |
| SDS |
Resources
| Recombinant Protein Resources |
Citations
van Dorp, Qiu, Choi et al
Elife (2021) 10 DOI: 10.7554/eLife.66194
Phan, Kim, Jo et al
Int J Mol Sci (2021) 22 (19) DOI: 10.3390/ijms221910847
Kar, Barak, Zerio et al
Function (Oxf) (2021) 2 (5), zqab036 DOI: 10.1093/function/zqab036
Kim, Park, Shin et al
PeerJ (2021) 9, e10973 DOI: 10.7717/peerj.10973
Woo, Nam, Kim et al
Korean J Physiol Pharmacol (2021) 25 (1), 87-94 DOI: 10.4196/kjpp.2021.25.1.87
Enomoto, Nishikawa, Back et al
J. Mol. Biol. (2019) 432 (2), 367-383 DOI: 10.1016/j.jmb.2019.10.003
Related Products
- Price:
- Actual Price:
Welcome to OriGene AI!
I'm your AI-powered guide to everything OriGene.
Ask me anything:
- Product specs
- Ordering help
- Technical questions
- How to find exactly what your experiment needs
Prefer a live agent? Connect with us by clicking the green chat icon, as seen in the image below or email our team at custsupport@origene.com.